Combined Use of Raltitrexed and S-1 as Treatment for Patients With Metastasizing Colorectal Cancer
NCT02618356
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
82
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Colon Cancer
Interventions
DRUG:
Raltitrexed and S-1
Sponsor
Fudan University